EMP3, was previously reported to be a tumor suppressor gene for several solid tumors, and is drawing attention as a novel prognostic marker, since its expression level or hypermethylation of the promoter region is associated with clinical prognosis in these cancer types [5]. The gene discussed is EMP3; the disease is neoplasm.